Assessing the use of antibiotics in pediatric patients hospitalized for varicella

Table 3 Main complications identified in ABX + group and ABX- group

Identified complication	Number of patients (%) ABX + group	Number of patients (%) ABX- group	p-value
Cutaneous	118 (34.2%)	17 (3.6%)	< 0.0001*
Respiratory	98 (28.4%)	13 (2.8%)	< 0.0001*
Hematological	91 (26.4%)	74 (15.9%)	0.0003*
Neurological	37 (10.7%)	108 (23.2%)	< 0.0001*
Hepatological	20 (5.8%)	28 (6.0%)	0.89
Others	63 (18.2%)	53 (11.4%)	0.005*

^*Data with statistical significance. To compare proportions or categorical outcomes chi-squared test or Fisher’s exact test (when appropriate) were performed

ISSN: 1824-7288